for merging. See templates for discussion to help reach a consensus. › Moclobemide, sold under the brand names Amira, Aurorix, Clobemix, Depnil and Manerix...
83 KB (9,161 words) - 12:35, 12 October 2024
used in the treatment of Parkinson's disease) and the reversible MAOI moclobemide provide a safer alternative and are now sometimes used as first-line...
37 KB (4,010 words) - 17:19, 13 October 2024
drug, moclobemide. "Hyperorgasmia". Archived from the original on 2012-04-26. Retrieved 2011-12-26. Lauerma H (June 1995). "A case of moclobemide-induced...
878 bytes (76 words) - 07:04, 23 August 2022
agitation or anxiety and has similar efficacy to the antidepressant drug moclobemide. This finding has also been validated by a group of general practitioners...
51 KB (5,052 words) - 20:12, 14 June 2024
harmine, although caution must be taken when choosing an MAOI. The use of moclobemide, a reversible inhibitor of monoamine oxidase-A (RIMA), has been recorded...
3 KB (310 words) - 08:20, 3 November 2023
(INN) Mobic mocetinostat (USAN, INN) mocimycin (INN) mociprazine (INN) moclobemide (INN) moctamide (INN) Moctanin modafinil (INN) modaline (INN) modecainide...
6 KB (324 words) - 16:09, 20 March 2022
citalopram in resistant OCD. Citalopram is well tolerated and as effective as moclobemide in social anxiety disorder. There are studies suggesting that citalopram...
48 KB (4,603 words) - 20:31, 27 October 2024
Eprobemide differs from moclobemide only in the linker that connects the morpholine fragment with the chlorobenzamide — moclobemide has two carbon atoms...
4 KB (192 words) - 02:09, 8 October 2024
Amitriptyline Bupropion Buspirone Desipramine Duloxetine Imipramine Milnacipran Moclobemide Nortriptyline Reboxetine Venlafaxine Miscellaneous/others Amantadine...
156 KB (15,400 words) - 11:43, 2 November 2024
treatment of depression, it has demonstrated similar efficacy to the MAOI moclobemide. It has also been used to treat nocturnal enuresis because of its ability...
54 KB (4,915 words) - 03:45, 26 October 2024
patients. There are also newer selective and reversible MAOIs, such as moclobemide, which carry a much lower risk of tyramine potentiation and have fewer...
21 KB (2,085 words) - 15:36, 5 October 2024
Amitriptyline Bupropion Buspirone Desipramine Duloxetine Imipramine Milnacipran Moclobemide Nortriptyline Reboxetine Venlafaxine Miscellaneous/others Amantadine...
260 KB (27,798 words) - 15:52, 4 November 2024
Miltefosine Minaprine Mirtazapine Misoprostol - Hospital authorization only. Moclobemide Molnupiravir Moperone Naloxone Naltrexone Nefazodone Nialamide Isobutyl...
26 KB (1,722 words) - 09:50, 2 November 2024
Discontinued/withdrawn Caroxazone (Surodil, Timostenil) Metralindole (Inkazan) Moclobemide (Aurorix, Manerix) Pirlindole (Pirazidol) These drugs are sometimes described...
18 KB (1,545 words) - 06:02, 22 October 2024
Monoamine oxidase A-selective Reversible: Eprobemide Metralindole Minaprine‡ Moclobemide Pirlindole Tetrindole Toloxatone MAOBTooltip Monoamine oxidase B-selective...
116 KB (11,202 words) - 23:02, 7 November 2024
Methaqualone, Methylphenidate, Mianserin, Mirtazapine, Mixed Amphetamine Salts, Moclobemide, Modafinil Naltrexone, Nitrazepam, Nortriptyline Olanzapine, Oxazepam...
3 KB (203 words) - 11:32, 30 September 2023
inhibitors, such as phenelzine (Nardil), tranylcypromine (Parnate), or moclobemide (Aurorix, Manerix). Serotonin reuptake inhibitors such as citalopram...
166 KB (15,980 words) - 00:16, 5 November 2024
drugs, including: Analgesics Ethenzamide Salicylamide Antidepressants Moclobemide Antiemetics/Prokinetics Alizapride Batanopride Bromopride Cinitapride...
6 KB (321 words) - 11:24, 24 October 2024
reuptake inhibitors, the serotonin-norepinephrine reuptake inhibitors, moclobemide and numerous others) it may also have a beneficial effect on cognition...
71 KB (6,477 words) - 13:32, 8 November 2024
that involved the use of either the monoamine oxidase inhibitor (MAOI) moclobemide or the selective serotonin reuptake inhibitor (SSRI) fluoxetine, Duarte...
23 KB (3,022 words) - 02:44, 26 March 2024
milnacipran), TCAs (e.g. amitriptyline, imipramine) MAOIs (e.g. selegiline, moclobemide). Antipsychotic drugs (e.g. aripiprazole, quetiapine) Schedule 5 (S5)...
17 KB (1,873 words) - 03:15, 26 October 2024
and 73%, mirtazapine 24%, nefazodone 8%, amineptine 7%, and moclobemide 4%. Moclobemide, a selective reversible MAO-A inhibitor, does not cause sexual...
193 KB (20,781 words) - 15:57, 6 November 2024
norharman, tetrahydroharmine) Methylene blue Metralindole Minaprine Moclobemide Pirlindole Sercloremine Tetrindole Toloxatone Inhibitors: MAO-B selective:...
103 KB (10,986 words) - 06:41, 16 September 2024
inhibitors (NRIs) desipramine and atomoxetine, the selective MAO-A inhibitor moclobemide, and the non-selective monoamine oxidase inhibitor pargyline, are ineffective...
21 KB (1,866 words) - 07:17, 19 October 2024
produced from freebase DMT, synthetic harmaline, MAOI medications (such as moclobemide) and other isolated or purified compounds or extracts. Archaeological...
91 KB (9,997 words) - 02:27, 3 November 2024
treatment options include pregabalin, tricyclic antidepressants, and moclobemide, among others. Anxiety is considered to be a serious psychiatric illness...
104 KB (11,468 words) - 13:13, 9 November 2024
(flumazenil), for the reversal of acute benzodiazepine effects. Aurorix (moclobemide), for depression. Avastin (bevacizumab), for certain malignant tumours...
57 KB (5,195 words) - 10:21, 4 November 2024
Amitriptyline Bupropion Buspirone Desipramine Duloxetine Imipramine Milnacipran Moclobemide Nortriptyline Reboxetine Venlafaxine Miscellaneous/others Amantadine...
149 KB (13,780 words) - 11:23, 2 November 2024
with monoamine oxidase inhibitors (e.g., furazolidone, isocarboxazid, moclobemide, phenelzine, procarbazine, selegiline, tranylcypromine). Such patients...
32 KB (3,138 words) - 05:41, 6 October 2024
"Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor – results of the drug utilization observation...
32 KB (3,388 words) - 19:38, 28 October 2024